Amphion Innovations Partner Company Motif BioSciences
Closes $1m Financing
New York City, April 05, 2007 – Amphion Innovations plc, a builder of companies in life sciences and technology, today announces that one of its partner companies, Motif BioSciences, Inc, a population genetics company in the Arabian Gulf Region, has raised $1 million in a Series C financing.
Amphion, which owns 42% of Motif, has invested $400,000 as part of this round. Motif is in the process of raising up to $3 million in capital and anticipates that it will conclude additional financing rounds in the coming months.
Full Story >>> |
Amphion Innovations plc Partner Company Motif BioSciences Announces Completion of $1.875 Million Financing and Commencement of Arabian Gulf Sampling Program
New York City, March 2, 2006 - Amphion Innovations plc's (LSE:AMP.L) partner company Motif BioSciences (Motif), a population genetics company focused on the discovery of genes causing common diseases by utilizing human genetic data from the Persian/Arabian Gulf region, announces that it has completed a $1.875 million financing and has received and begun analyzing the first sets of human genetic samples from the Arabian Gulf.
Full Story >>> |
